trial · primary record
Naltrexone: Vivitrol®
Methamphetamine Use Disorder
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 403 |
| Primary completion | 2019-07-25 |
| Primary endpoint | Number of Participants With Treatment Response During Medication Phase at Stage 1 |
| Registry ID | NCT03078075 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:29.319Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03078075
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.